Abstract: Cosmetic of a) a cosmetic preparation which contains one or more oils liquid at 20° C. and having a spreadability value of less than 550 mm/10 min and b) packaging of HDPE, LDPE or PP combined with a 1-propene-ethylene copolymer.

Abstract: The invention relates to a hydrodispersion, comprising thickeners, waxes, and oils. The waxes and the overall preparation have specific melting ranges that ensure a pleasant, sensorily light profile and good care effects.

Abstract: The present invention relates to a method for the production of nanoparticulate metal(III) vanadates or vanadate/phosophate mixed crystals, comprising the reaction in a reaction medium of a reactive vanadate source and optionally a phosphate source dissolvable or dispersible in the reaction medium and of a reactive metal(III) salt dissolvable or dispersible in the reaction medium under heating, wherein the reaction medium contains water and a polyol in a volume ratio of 20/80 to 90/10, and the particles thereby obtained. The synthesis provides a high yield of metal(III) vanadate or vanadate/phosphate having a narrow particle size distribution. Doped embodiments thereof are distinguished by excellent luminescence properties.

Abstract: The invention belongs to the field of animal health and in particular Bovine Viral Diarrhea Virus (BVDV). The invention provides infectious BVDV clones and methods to produce said BVDV clones. The invention further relates to methods of attenuating said clones, attenuated BVDV clones and vaccines comprising said attenuated clones.

Abstract: Luminescent inorganic nanoparticles comprising: (a) a core made from a first metal salt or oxide being surrounded by (b) a shell made from a second metal salt or oxide being luminescent and having non-semiconductor properties. These nanoparticles can be advantageously used in (fluorescence) resonance energy transfer ((F)RET)-based bioassays in view of their higher (F)RET efficiency.

Abstract: The present invention relates to Luminescent nanoparticles comprising (a) a core made from a luminescent metal salt selected from phosphates, sulfates or fluorides, being surrounded by (b) a shell made from a metal salt or oxide capable of preventing or reducing energy transfer from the core after its electronic excitation to the surface of the nanoparticle, e.g. a shell made from a non-luminescent metal salt or oxide, which are characterized by higher quantum yields and can be used in various fields including light generation and security marking.

Abstract: Attenuated pestiviruses, in particular attenuated BVDV, wherein at least one mutation is in the coding sequence for glycoprotein Ems and at least another mutation in the coding sequence for Npro which preferably leads to combined inactivation of the RNase activity residing in glycoprotein Ems in addition to the inactivation of the (hypothesized) immunomodulating activity residing in Npro. Methods for attenuating pestiviruses such as BVDV, nucleic acids encoding the pestiviruses, in particular BVDV, compositions and vaccines comprising the attenuated pestiviruses, in particular BVDV, of the invention.

Abstract: A process for synthesizing nanoparticles, in particular metal salt nanoparticles. To the synthesis mixture is added a modifying reagent which binds, by means of a first functional group, to the nanoparticle surface and which carries a second functional group for binding to molecules which are specifically selected in dependence on the subsequent use of the nanoparticles. This dispenses with a postsynthetic, separate, application-specific modification step. A new substance class, the pentaalkyl iminobis(methylenephosphono)carboxylates, are particularly suitable for this purpose.

Abstract: The invention relates to synthesis of nanoparticles, in particular to methods for producing nanoparticles with networks consisting of Z sulphate (Z=magnesium (Mg), calcium (Ca), strontium (Sr), barium (Ba) or the binary mixtures thereof). The inventive method consists in synthesising the nanoparticles by crystal growth from an ion Z source and a sulphate ion source in a liquid phase mixture. The invention produces Z sulphate nanoparticles having a small diameter and uniformly dispersible in water or other solvents in a simple way. Co-ordinating solvents like glycerine, glycol ethylene and other polyethylene glycols, polyalcohols or dimethylsulphoxide (DMSO) are used for the synthesis mixture.

Abstract: The present invention relates to a method for the production of nanoparticulate metal(III) vanadates or vanadate/phosophate mixed crystals, comprising the reaction in a reaction medium of a reactive vanadate source and optionally a phosphate source dissolvable or dispersible in the reaction medium and of a reactive metal(III) salt dissolvable or dispersible in the reaction medium under heating, wherein the reaction medium contains water and a polyol in a volume ratio of 20/80 to 90/10, and the particles thereby obtained. The synthesis provides a high yield of metal(III) vanadate or vanadate/phosphate having a narrow particle size distribution. Doped embodiments thereof are distinguished by excellent luminescence properties.

Abstract: The present invention relates to luminescent inorganic nanoparticles comprising (a) a core made from a first metal salt or oxide being surrounded by (b) a shell made from a second metal salt or oxide being luminescent and having non-semiconductor properties. These particles can be advantageously used in (fluorescence) resonance energy transfer ((F)RET)-based bioassays in view of their higher (F)RET efficiency.

Abstract: The present invention relates to Luminescent nanoparticles comprising (a) a core made from a luminescent metal salt selected from phosphates, sulfates or fluorides, being surrounded by (b) a shell made from a metal salt or oxide capable of preventing or reducing energy transfer from the core after its electronic excitation to the surface of the nanoparticle, e.g. a shell made from a non-luminescent metal salt or oxide, which are characterized by higher quantum yields and can be used in various fields including light generation and security marking.

Abstract: The invention belongs to the field of animal health and in particular Bovine Viral Diarrhea Virus (BVDV). The invention provides infectious BVDV clones and methods to produce said BVDV clones. The invention further relates to methods of attenuating said clones, attenuated BVDV clones and vaccines comprising said attenuated clones.

Abstract: The invention belongs to the field of animal health and in particular Bovine Viral Diarrhea Virus (BVDV). The invention provides infectious BVDV clones and methods to produce said BVDV clones. The invention further relates to methods of attenuating said clones, attenuated BVDV clones and vaccines comprising said attenuated clones.

Abstract: The invention relates to synthesis of nanoparticles, in particular to methods for producing nanoparticles with a net-works consisting of Z sulphate (Z=magnesium (Mg), calcium (Ca), strontium (Sr), barium (Ba) or the binary mixtures thereof). The inventive method consists in synthesising the nanoparticles by crystal growth from an ion Z source and a sulphate ion source in a synthesis liquid phase mixture. The aim of said invention is to produce in a simple way barium sulphate nanoparticles having a small diameter, said particles being uniformly dispersed in water or other solvents. For this purpose, co-ordinating solvents like glycerine, glycol ethylene and other polyethylene glycols, polyalcohols or dimethylsulphoxide (DMSO) are used for the synthesis mixture. In the preferred embodiment, barium is used in the form of chloride and the sulphate source in the form of tetrabutylammonium hydrogen sulphate. Other metallic dopants can be eventually integrated in the nanoparticles network.

Abstract: A process for synthesizing nanoparticles, in particular metal salt nanoparticles. To the synthesis mixture is added a modifying reagent which binds, by means of a first functional group, to the nanoparticle surface and which carries a second functional group for binding to molecules which are specifically selected in dependence on the subsequent use of the nanoparticles. This dispenses with a postsynthetic, separate, application-specific modification step. A new substance class, the pentaalkyl iminobis(methylenephosphono) carboxylates, are particularly suitable for this purpose.

Abstract: The invention belongs to the field of animal health and in particular Bovine Viral Diarrhea Virus (BVDV). The invention provides infectious BVDV clones and methods to produce said BVDV clones. The invention further relates to methods of attenuating said clones, attenuated BVDV clones and vaccines comprising said attenuated clones.